Headache and mental disorders in practice
Views: 10DOI:
https://doi.org/10.48208/HeadacheMed.2025.23Keywords:
Headache, Migraine disorders, Depressive disorders, Anxiety disorders, Quality of lifeAbstract
Introduction
Migraine is a major cause of global functional disability and is frequently associated with psychiatric disorders such as anxiety and depression. Although the literature highlights this association, few studies have explored these relationships in real-life contexts, outside controlled clinical environments.
Objective
To analyze the relationship between anxiety and depression levels and the impact of headache on the quality of life of patients with migraine in a real-life context.
Methods
A prospective longitudinal observational study was conducted between January and December 2024, involving 46 patients treated at a tertiary headache center. Data were collected using the REBRACEF questionnaire. Statistical analyses included correlation tests and comparisons between the MIDAS, PHQ-9, and GAD-7 scales, as well as the variables sex and age.
Results
The majority of participants were female (87%), with a mean age of 44.5 years. A significant negative correlation was found between age and MIDAS score (p=0.036), suggesting greater functional impact in younger patients. No significant correlation was found between MIDAS and PHQ-9 or GAD-7 scores. However, a positive correlation was observed between PHQ-9 and GAD-7 scores (p<0.001), indicating comorbidity between depression and anxiety.
Conclusion
The findings suggest that younger patients experience greater functional impairment due to migraine. Despite the high prevalence of anxiety and depression symptoms, these comorbidities did not show a direct association with the functional impact of pain. The results underscore the importance of multidimensional approaches and highlight the need for studies with larger samples and longitudinal designs.
Downloads
References
Kirst F de O, Daudt AD, Daudt CVG. Cefaleias primárias: diagnóstico e tratamento. Acta Méd 2014;35.
Schoonman G, Evers D, Terwindt G, van Dijk J, Ferrari M. The Prevalence of Premonitory Symptoms in Migraine: A Questionnaire Study in 461 Patients. Cephalalgia 2006;26:1209–13. Doi:10.1111/j.1468-2982.2006.01195.x.
Milde‐Busch A, Blaschek A, Borggräfe I, Heinen F, Straube A, Von Kries R. Associations of Diet and Lifestyle With Headache in High‐School Students: Results From a Cross‐Sectional Study. Headache: The Journal of Head and Face Pain 2010;50:1104–14. Doi:10.1111/j.1526-4610.2010.01706.x.
Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008;7:354–61. Doi:10.1016/S1474-4422(08)70062-0.
Oliveira MC, Tenconi JK, Breda D. Análise da relação entre enxaqueca e ansiedade em serviço ... Revista Thêma et Scientia 2024;14.
Érica C Santos, Juliane P P Mercante, André M S Silva, Rosana T Miyazaki, Pamella F Daud, Arao B Oliveira, et al. The impact of anxiety and depression on migraine patients’ journey to a tertiary headache center. Headache Medicine 2019;10:174–81. Doi:10.48208/HeadacheMed.2019.25.
Peres MFP, Mercante JPP, Tobo PR, Kamei H, Bigal ME. Anxiety and depression symptoms and migraine: a symptom-based approach research. J Headache Pain 2017;18:37. Doi:10.1186/s10194-017-0742-1.
Minen MT, Begasse De Dhaem O, Kroon Van Diest A, Powers S, Schwedt TJ, Lipton R, et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 2016;87:741–9. Doi:10.1136/jnnp-2015-312233.
Grassi V, Jurno ME, Fröhlich AC, Rieder CR de M, Sarmento EM, Pereira JK, et al. Brazilian headache registry: methods and preliminary data of the pilot study. Arq Neuropsiquiatr 2023;81:740–7. Doi:10.1055/s-0043-1771175.
Lipton R, Kolodner K, Bigal M, Valade D, Láinez M, Pascual J, et al. Validity and Reliability of the Migraine-Treatment Optimization Questionnaire. Cephalalgia 2009;29:751–9. Doi:10.1111/j.1468-2982.2008.01786.x.
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med 2001;16:606–13. Doi:10.1046/j.1525-1497.2001.016009606.x.
Seo J-G, Park S-P. Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine. J Headache Pain 2015;16:65. Doi:10.1186/s10194-015-0552-2.
Seo J-G, Park S-P. Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. J Headache Pain 2015;16:97. Doi:10.1186/s10194-015-0583-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Rayane Mara Guimarães Souza, Laísla Natiele da Silva Oliveira, Danilo Jorge da Silva, Lígia Barros de Oliveira, Vanise Grassi, Mauro Eduardo Jurno (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.